Northern Trust Company of Connecticut’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
$101M Sell
3,465,708
-19,751
-0.6% -$575K 0.63% 10
2013
Q3
$95M Sell
3,485,459
-54,606
-2% -$1.49M 0.61% 7
2013
Q2
$94.1M Buy
+3,540,065
New +$97.8M 0.64% 8

Other funds holding PFE

Northern Trust Company of Connecticut's PFE Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Pfizer (PFE) stake by 0.57% in Q4 2013, selling an estimated $575K and leaving 3,465,708 shares worth $101M. The position accounts for 0.63% of the portfolio, ranked #10.

Northern Trust Company of Connecticut first reported a position in PFE in Q2 2013 and has held it in 3 quarters since. 1,737 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

  • Northern Trust Company of Connecticut held 3,465,708 shares of Pfizer worth $101M as of Q4 2013.
  • Northern Trust Company of Connecticut sold 19,751 Pfizer shares in Q4 2013, an estimated $575K.
  • Pfizer made up 0.63% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #10 holding.
  • Northern Trust Company of Connecticut first reported a position in Pfizer in Q2 2013 and has held it in 3 quarters since.
  • 1,737 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.